# Palonosetron and Blood Coagulation

> **NCT04507711** · NA · UNKNOWN · sponsor: **Seoul National University Bundang Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Blood Coagulation Disorder

## Interventions

- **DRUG:** 0 ul of palonosetron
- **DRUG:** 1 ul of palonosetron
- **DRUG:** 10 ul of palonosetron
- **DRUG:** 100 ul of palonosetron

## Key facts

- **NCT ID:** NCT04507711
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-16
- **Primary completion:** 2023-11-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04507711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04507711, "Palonosetron and Blood Coagulation". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT04507711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*